Over-expression of DNA repair genes has been associated with resistance to radiation and DNA-damage induced by chemotherapeutic agents such as cisplatin. More recently, based on the analysis of genome expression profiling, it was proposed that over-expression of DNA repair genes enhances the invasive behaviour of tumour cells. In this study we present experimental evidence utilizing functional assays to test this hypothesis. We assessed the effect of the DNA repair proteins known as X-ray complementing protein 3 (XRCC3) and RAD51, to the invasive behavior of the MCF-7 luminal epithelial-like and BT20 basal-like triple negative human breast cancer cell lines. We report that stable or transient over-expression of XRCC3 but not RAD51 increased...
Impaired DNA repair drives mutagenicity, which increases neoantigen load and immunogenicity. We inve...
A large proportion of breast cancer patients are treated with radiotherapy. Ionising radiation induc...
The development of drug resistance in tumor cells is a multi-factorial process. Besides, a cross-res...
Over-expression of DNA repair genes has been associated with resistance to radiation and DNA-damage ...
Acquisition of invasiveness through extracellular matrix is a crucial characteristic of transition t...
Impaired DNA repair drives mutagenicity, which increases neoantigen load and immunogenicity. We inve...
Abstract Genomic instability is a common hallmark of human tumours. As a carrier of genetic informat...
Overexpression of the DNA repair protein, X-ray repair cross-complementing protein 3 (XRCC3), has be...
DNA repair defects have been increasingly focused on as therapeutic targets. In hormone-positive bre...
AIMS: XRCC3 and RAD51 are two important members in homologous recombination repair pathway. This stu...
Aims: XRCC3 and RAD51 are two important members in homologous recombination repair pathway. This stu...
XRCC3 and RAD51 are two important members in homologous recombination repair pathway. This study was...
Interactions between DNA repair proteins Rad51 and XRCC3 were explored to investigate their roles in...
An acquired genetic instability, resulting from the loss of some types of DNA repair, is an early ev...
The X-ray repair cross complementing 1 (XRCC1) protein is required for viability and efficient repai...
Impaired DNA repair drives mutagenicity, which increases neoantigen load and immunogenicity. We inve...
A large proportion of breast cancer patients are treated with radiotherapy. Ionising radiation induc...
The development of drug resistance in tumor cells is a multi-factorial process. Besides, a cross-res...
Over-expression of DNA repair genes has been associated with resistance to radiation and DNA-damage ...
Acquisition of invasiveness through extracellular matrix is a crucial characteristic of transition t...
Impaired DNA repair drives mutagenicity, which increases neoantigen load and immunogenicity. We inve...
Abstract Genomic instability is a common hallmark of human tumours. As a carrier of genetic informat...
Overexpression of the DNA repair protein, X-ray repair cross-complementing protein 3 (XRCC3), has be...
DNA repair defects have been increasingly focused on as therapeutic targets. In hormone-positive bre...
AIMS: XRCC3 and RAD51 are two important members in homologous recombination repair pathway. This stu...
Aims: XRCC3 and RAD51 are two important members in homologous recombination repair pathway. This stu...
XRCC3 and RAD51 are two important members in homologous recombination repair pathway. This study was...
Interactions between DNA repair proteins Rad51 and XRCC3 were explored to investigate their roles in...
An acquired genetic instability, resulting from the loss of some types of DNA repair, is an early ev...
The X-ray repair cross complementing 1 (XRCC1) protein is required for viability and efficient repai...
Impaired DNA repair drives mutagenicity, which increases neoantigen load and immunogenicity. We inve...
A large proportion of breast cancer patients are treated with radiotherapy. Ionising radiation induc...
The development of drug resistance in tumor cells is a multi-factorial process. Besides, a cross-res...